Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -29.30K | 12.20K | -599.10K | -378.30K | -718.60K |
| Total Depreciation and Amortization | 6.30K | 6.30K | 6.20K | 6.10K | 6.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.60K | -100.40K | -174.60K | -215.20K | -221.40K |
| Change in Net Operating Assets | -425.40K | -694.50K | -131.40K | -608.30K | 155.60K |
| Cash from Operations | -399.90K | -776.40K | -898.80K | -1.20M | -778.50K |
| Capital Expenditure | -1.60K | -1.60K | -1.60K | -1.60K | -4.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.20K | -55.60K | 126.00K | 125.00K | 153.80K |
| Cash from Investing | -64.80K | -57.20K | 124.40K | 123.40K | 148.80K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 17.23M | 17.23M | 17.23M | 9.74M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.63M | 1.63M | 1.63M | 911.20K | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -100.00 | -- | -- | -- | -- |
| Net Change in Cash | 1.17M | 796.60K | 855.80K | -161.20K | -629.60K |